Skip to main content
Premium Trial:

Request an Annual Quote

Biocius, BlueSky Partner to Offer Sirtuin Enzyme Preparations

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biocius Life Sciences and BlueSky Biotech today announced a collaboration to offer what they said is the industry's only sirtuin enzyme preparations that are fully validated in a label-free functional assay.

The collaboration builds on an existing relationship and "will significantly improve drug discovery efficiency of the SIRT [silent mating type information regulation homolog] class of epigenetic modulating enzymes," the companies said in a statement. SIRTs are being researched as potential therapeutics for several indications, they added.

Financial terms of the deal were not disclosed.

The two firms intend to launch a selectivity panel of sirtuins and histone deacetylases as part of the partnership. The first release, of SIRT1, has been linked to the regulation of multiple cellular processes, such as insulin signaling, apoptosis, and cancer, Biocius and BlueSky said. Additional releases of validated enzymes are anticipated during the coming months.

Based in Wakefield, Mass., Biocius provides mass spectrometry-based services and products primarily for drug-discovery purposes. The company was spun out of Biotrove after that firm was acquired by Life Technologies late last year.

BlueSky, based in Worcester, Mass., is a contract research organization and provides services for pharmaceutical R&D.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.